A Double‐Blind Evaluation of Topical Levocabastine, a New Specific H1 Antagonist in Patients with Allergic Conjunctivitis
@article{Pipkorn1985ADE, title={A Double‐Blind Evaluation of Topical Levocabastine, a New Specific H1 Antagonist in Patients with Allergic Conjunctivitis}, author={U. Pipkorn and M. Bende and J. Hedner and T. Hednerm}, journal={Allergy}, year={1985}, volume={40} }
Forty patients suffering from allergic conjunctivitis, due to birch pollen, participated in a double‐blind parallel group comparison between levocabastine (a potent new specific histamine (H1) antagonist) and placebo, both given as eye drops. Symptom scores were recorded during a 4‐week period. A 1‐week run‐in period was followed by a 3‐week treatment period. To enable a fair evaluation of the treatment effect on the ocular symptoms only, all patients were treated with topical nasal… CONTINUE READING
Topics from this paper
62 Citations
Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis
- Medicine
- Allergy
- 1987
- 56
Effect of topical levocabastine on allergic and non‐allergic perennial rhinitis
- Medicine
- Allergy
- 1988
- 28
A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen‐provoked allergic conjunctivitis
- Medicine
- Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
- 1993
- 34
Effect of levocabastine, a new H1 antagonist, in a conjunctival provocation test with allergens.
- Medicine
- The Journal of allergy and clinical immunology
- 1988
- 37
Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis
- Medicine
- Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
- 1991
- 35
Azelastine eye‐drops in seasonal allergic conjunctivitis or rhinoconjunctivitis.
- Medicine
- Allergy
- 1998
- 22
Efficacy and Safety of Topical Azelastine Compared With Topical Mitomycin C in Patients With Allergic Conjunctivitis
- Medicine
- Cornea
- 2003
- 5
Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitis.
- Medicine
- The Journal of allergy and clinical immunology
- 1994
- 41
References
SHOWING 1-10 OF 32 REFERENCES
Antazoline phosphate and naphazoline hydrochloride, singly and in combination for the treatment of allergic conjunctivitis-a controlled, double-blind clinical trial.
- Medicine
- Annals of allergy
- 1975
- 19
Effect of the H1 Antihistamine Chlorpheniramine Maleate on Histamine‐Induced Symptoms in the Human Conjunctiva
- Medicine
- Allergy
- 1982
- 37
Allergic perennial and non-allergic, vasomotor rhinitis treated with budesonide nasal spray.
- Medicine
- Rhinology
- 1980
- 24
Significance of H1 and H2 receptors in the human nose: rationale for topical use of combined antihistamine preparations.
- Medicine
- The Journal of allergy and clinical immunology
- 1982
- 122
Local Effect of Intranasal Beclomethasone Dipropionate Aerosol in Hay Fever
- Medicine
- British medical journal
- 1973
- 140
- PDF
A substance P antagonist, [D-Pro2, D-Trp7,9]SP, inhibits inflammatory responses in the rabbit eye.
- Biology, Medicine
- Science
- 1981
- 126